Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Inoue

Showing results (221-230 of 387) with videos related to

Pageof 39
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2014
Phase II study of Amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma: North Japan Lung Cancer group study 0803Akira Inoue, Shunichi Sugawara, Masao Harada, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 21, 2021
Appropriate referral timing to specialized palliative care service: survey of bereaved families of cancer patients who died in palliative care unitsKeita Tagami, Kento Masukawa, Akira Inoue, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapyGiorgio Scagliotti, Makoto Nishio, Miyako Satouchi, et al.
Expert Opinion on Pharmacotherapy|January 20, 2015
First-line gefitinib for elderly patients with advanced NSCLC harboring EGFR mutations. A combined analysis of North-East Japan Study Group studiesNaoto Morikawa, Yuji Minegishi, Akira Inoue, et al.
Japanese Journal of Clinical Oncology|April 17, 2015
Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002)Eisaku Miyauchi, Akira Inoue, Kunihiko Kobayashi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861QSatoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa, et al.
Oncology Letters|April 16, 2025
Outcomes of neoadjuvant chemoradiotherapy for locally advanced rectal cancer under non‑smoking conditions confirmed by measuring expiratory CO levels: An observational studyAkira Inoue, Yoshinori Kagawa, Yujiro Nishizawa, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 18, 2002
[A case of chronic thromboembolic pulmonary hypertension based on essential thrombocythemia]Naohiko Shishido, Akira Inoue, Hiroshi Morishita, et al.
BMC Infectious Diseases|July 22, 2024
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibodyShuhei Maruyama, Daiki Wada, Shuji Kanayama, et al.
BMC Palliative Care|January 22, 2026
Monitoring patients' symptom improvement in palliative care units using patient-reported outcomes: a multicenter prospective observational studyNatsuko Katsube, Akihiro Sakashita, Kyoko Kamohara, et al.
Pageof 39

Showing results (221-230 of 387) with videos related to

Sort By:
Pageof 39
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2014
Phase II study of Amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma: North Japan Lung Cancer group study 0803Akira Inoue, Shunichi Sugawara, Masao Harada, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 21, 2021
Appropriate referral timing to specialized palliative care service: survey of bereaved families of cancer patients who died in palliative care unitsKeita Tagami, Kento Masukawa, Akira Inoue, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapyGiorgio Scagliotti, Makoto Nishio, Miyako Satouchi, et al.
Expert Opinion on Pharmacotherapy|January 20, 2015
First-line gefitinib for elderly patients with advanced NSCLC harboring EGFR mutations. A combined analysis of North-East Japan Study Group studiesNaoto Morikawa, Yuji Minegishi, Akira Inoue, et al.
Japanese Journal of Clinical Oncology|April 17, 2015
Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002)Eisaku Miyauchi, Akira Inoue, Kunihiko Kobayashi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861QSatoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa, et al.
Oncology Letters|April 16, 2025
Outcomes of neoadjuvant chemoradiotherapy for locally advanced rectal cancer under non‑smoking conditions confirmed by measuring expiratory CO levels: An observational studyAkira Inoue, Yoshinori Kagawa, Yujiro Nishizawa, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 18, 2002
[A case of chronic thromboembolic pulmonary hypertension based on essential thrombocythemia]Naohiko Shishido, Akira Inoue, Hiroshi Morishita, et al.
BMC Infectious Diseases|July 22, 2024
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibodyShuhei Maruyama, Daiki Wada, Shuji Kanayama, et al.
BMC Palliative Care|January 22, 2026
Monitoring patients' symptom improvement in palliative care units using patient-reported outcomes: a multicenter prospective observational studyNatsuko Katsube, Akihiro Sakashita, Kyoko Kamohara, et al.
Pageof 39